Ares Financial Consulting’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$65.2K Hold
457
– – 0.05% 191
2026
Q2
$71.6K Sell
457
-90
-16% -$13.5K 0.05% 179
2026
Q1
$84.8K Buy
+547
New +$83.8K 0.07% 153

Other funds holding NVS

Ares Financial Consulting's NVS Position: Q3 2026 in Review

Ares Financial Consulting held its Novartis (NVS) position steady in Q3 2026 at 457 shares worth $65.2K. The position accounts for 0.05% of the portfolio, ranked #191.

Ares Financial Consulting first reported a position in NVS in Q1 2026 and has held it in 3 quarters since. The position peaked at $84.8K in Q1 2026. 1,543 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Ares Financial Consulting held 457 shares of Novartis worth $65.2K as of Q3 2026.
  • Ares Financial Consulting left its Novartis share count unchanged in Q3 2026.
  • Novartis made up 0.05% of Ares Financial Consulting's portfolio in Q3 2026, its #191 holding.
  • Ares Financial Consulting first reported a position in Novartis in Q1 2026 and has held it in 3 quarters since.
  • Ares Financial Consulting's Novartis position peaked at $84.8K in Q1 2026.
  • 1,543 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Ares Financial Consulting's 13F filing for Q3 2026, filed 19 Oct 2026.